BiotechTube
Home/Madrigal Pharmaceuticals/Bill Sibold
BS

Bill Sibold

Chief Executive Officer and Director

Madrigal Pharmaceuticals

Therapeutic Areas

HepatologyMetabolic DiseasesMASH/NASHLiver Disease

Madrigal Pharmaceuticals Pipeline

DrugIndicationPhase
ResmetiromMASH with moderate to advanced fibrosis (F2-F3)Approved
Ervogastat combinationMASHPhase 2
MGL-2086UndisclosedPhase 1

Leadership Team at Madrigal Pharmaceuticals

DS
David Soergel, M.D.
Executive Vice President, Chief Medical Officer
RT
Rebecca Taub, M.D.
Founder and Director, Senior Scientific and Medical Advisor
View full Madrigal Pharmaceuticals profile